We recently published a list of 10 Most Promising Gene Editing Stocks to Buy According to Hedge Funds. In this article, we ...

We recently published a list of 10 Most Promising Gene Editing Stocks to Buy According to Hedge Funds. In this article, we ...

Apr. 23, 2024 — Researchers describe the steps they took to manipulate DNA and proteins -- essential building blocks of life -- to create cells that look and act like cells from the body. This ...

We recently published a list of 10 Most Promising Gene Editing Stocks to Buy According to Hedge Funds. In this article, we ...

African governments have been urged to prioritise investment in biotechnology research and development to address pressing ...

Insilico Medicine (“Insilico”), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, today ...

My work has revolved around facilitating the safe use of modern biotechnology in agriculture and health, with a strong emphasis on capacity building for environmental and biosafety regulators ...

The Minister stressed that developing indigenous expertise would strengthen India’s influence in global science and ...

The cytokinins market is projected to experience robust growth, with an anticipated compound annual growth rate (CAGR) of 7.9 ...

ENHERTU is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca.

Final analysis from IGNITE Phase 2 clinical trial evaluating iluzanebart in ALSP planned for first half of 2025 -- Data from Phase 1 clinical ...

Vigil Neuroscience routinely posts information that may be important to investors in the “Investors” section of its website at https://www.vigilneuro.com. The company encourages investors and ...